Wilbur Pan
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- CAR-T cell therapy research
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 19
- Cancer Immunotherapy and Biomarkers 17
- Colorectal Cancer Treatments and Studies 4
- Cancer Treatment and Pharmacology 4
-
- Breast Cancer Treatment Studies 7
- Cancer Genomics and Diagnostics 2
- Co-authors
- Javier Cortés (11 shared papers)Peter Schmid (5 shared papers)Norikazu Masuda (5 shared papers)Zifang Guo (2 shared papers)Mastura Md Yusof (4 shared papers)Vassiliki Karantza (4 shared papers)Hiroji Iwata (3 shared papers)Xuan Zhou (2 shared papers)
- Journals
- Annals of Oncology (3 papers)Cancer Research (3 papers)Journal of the National Comprehensive Cancer Network (2 papers)Future Oncology (2 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesSpainUnited Kingdom
In The Last Decade
Wilbur Pan
18 papers receiving 773 citations
Wilbur Pan's Hit Papers
Peers
Comparison fields: 5 of 59
- Oncology 614
- Cancer Research 246
- Immunology 178
- Pulmonary and Respiratory Medicine 231
- Genetics 28
Countries citing papers authored by Wilbur Pan
This map shows the geographic impact of Wilbur Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wilbur Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wilbur Pan more than expected).
Fields of papers citing papers by Wilbur Pan
This network shows the impact of papers produced by Wilbur Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wilbur Pan. The network helps show where Wilbur Pan may publish in the future.
Co-authors
The 25 scholars most cited alongside Wilbur Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer Hit paper breakdown → | 2022 | 594 |
| 2 | Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522 Hit paper breakdown → | 2024 | 47 |
| 3 | 2022 | 35 | |
| 4 | 2023 | 17 | |
| 5 | 2023 | 14 | |
| 6 | 2023 | 13 | |
| 7 | 2022 | 12 | |
| 8 | 2024 | 11 | |
| 9 | 2024 | 7 | |
| 10 | 2022 | 7 | |
| 11 | 2022 | 6 | |
| 12 | 2024 | 5 | |
| 13 | 2023 | 5 | |
| 14 | 2024 | 5 | |
| 15 | 2022 | 2 | |
| 16 | 2022 | 1 | |
| 17 | 2023 | 1 | |
| 18 | 2022 | 1 | |
| 19 | 2024 | 0 |
About Wilbur Pan
Wilbur Pan is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Surgery and Economics and Econometrics, having authored 19 papers that have together received 783 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (17 papers), Breast Cancer Treatment Studies (7 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer Treatment and Pharmacology (4 papers), Advanced Breast Cancer Therapies (3 papers), Esophageal Cancer Research and Treatment (3 papers), Cancer Genomics and Diagnostics (2 papers) and Economic and Financial Impacts of Cancer (2 papers). The work is most often cited by research in Oncology (614 citations), Cancer Research (246 citations), Immunology (178 citations), Pulmonary and Respiratory Medicine (231 citations) and Genetics (28 citations). Wilbur Pan has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Javier Cortés, Peter Schmid, Norikazu Masuda, Zifang Guo, Mastura Md Yusof, Vassiliki Karantza, Hiroji Iwata, Xuan Zhou, Seock‐Ah Im and David W. Cescon. Their work appears in journals such as Annals of Oncology, Cancer Research, Journal of the National Comprehensive Cancer Network, Future Oncology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.